Disseminated Cryptococcal Disease in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib
Cryptococcus is a unique environmental fungus that can cause disease most often in immunocompromised individuals with defective cell-mediated immunity. Chronic lymphocytic leukemia (CLL) is not known to be a risk factor for cryptococcal disease although cases have been described mainly in patients t...
Main Authors: | Koh Okamoto, Laurie A. Proia, Patricia L. Demarais |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2016/4642831 |
Similar Items
-
Disseminated cryptococcal infection in a patient with treatment-naïve chronic lymphocytic leukemia (CLL)
by: Adam Suleman, et al.
Published: (2019-01-01) -
Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia
by: EA Stadnik, et al.
Published: (2018-01-01) -
Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia
by: Bartosz Puła, et al.
Published: (2019-11-01) -
Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia
by: EA Nikitin, et al.
Published: (2017-07-01) -
Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib
by: Katherine R. Sittig, et al.
Published: (2021-01-01)